Acceptability of prophylactic human papillomavirus vaccination among adult men.
OBJECTIVE
HPV vaccine acceptability was examined as part of a cohort study of HPV infection among adult males.


RESULTS
Overall, 69% of men reported that they were likely or very likely to be vaccinated against HPV if a prophylactic vaccine were available. Men most frequently cited side effects (69%), efficacy (65%), and safety (63%) as the major factors that would influence their decision to be vaccinated against HPV. Issues of vaccine costs and efficacy were important considerations for men of vaccine-eligible ages (18-26 years). Men who cited cost as a major factor in their HPV vaccine decisions and those indicating cost as a potential barrier had greater intention to be vaccinated. Heterosexual men had less intention to be vaccinated compared to men who have sex with men.


METHODS
Between July 2004 and June 2007, 445 adult males aged ≥18 years were enrolled primarily from a university-based population. A structured questionnaire addressed HPV vaccine awareness, attitudes, and intention to be vaccinated.


CONCLUSIONS
Acceptability of HPV vaccination among males is generally high. Costs and sexual history may influence vaccine utilization.
Hernandez
Brenda Y
BY
Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI, USA. brenda@crch.hawaii.edu
Wilkens
Lynne R
LR
Thompson
Pamela J
PJ
Shvetsov
Yurii B
YB
Goodman
Marc T
MT
Ning
Lily
L
Kaopua
Lana
L
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care; D014611:Vaccination
D053918:Papillomavirus Vaccines